Life-Threatening Complications of Influenza vs Coronavirus Disease 2019 (COVID-19) in US Children
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com..
BACKGROUND: Clinical differences between critical illness from influenza infection vs coronavirus disease 2019 (COVID-19) have not been well characterized in pediatric patients.
METHODS: We compared demographics, clinical characteristics, and outcomes of US children (aged 8 months to 17 years) admitted to the intensive care or high-acuity unit with influenza or COVID-19. Using mixed-effects models, we assessed the odds of death or requiring life support for influenza vs COVID-19 after adjustment for age, sex, race and Hispanic origin, and underlying conditions including obesity.
RESULTS: Children with influenza (n = 179) were younger than those with COVID-19 (n = 381; median, 5.2 years vs 13.8 years), less likely to be non-Hispanic Black (14.5% vs 27.6%) or Hispanic (24.0% vs 36.2%), and less likely to have ≥1 underlying condition (66.4% vs 78.5%) or be obese (21.4% vs 42.2%), and a shorter hospital stay (median, 5 days vs 7 days). They were similarly likely to require invasive mechanical ventilation (both 30.2%), vasopressor support (19.6% and 19.9%), or extracorporeal membrane oxygenation (2.2% and 2.9%). Four children with influenza (2.2%) and 11 children with COVID-19 (2.9%) died. The odds of death or requiring life support in children with influenza vs COVID-19 were similar (adjusted odds ratio, 1.30; 95% confidence interval, .78-2.15; P = .32).
CONCLUSIONS: Despite differences in demographics and clinical characteristics of children with influenza or COVID-19, the frequency of life-threatening complications was similar. Our findings highlight the importance of implementing prevention measures to reduce transmission and disease severity of influenza and COVID-19.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:76 |
|---|---|
| Enthalten in: |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 76(2023), 3 vom: 08. Feb., Seite e280-e290 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Halasa, Natasha B [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 10.02.2023 Date Revised 29.09.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/cid/ciac477 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM342389165 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM342389165 | ||
| 003 | DE-627 | ||
| 005 | 20231226014012.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/cid/ciac477 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1141.xml |
| 035 | |a (DE-627)NLM342389165 | ||
| 035 | |a (NLM)35717646 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Halasa, Natasha B |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Life-Threatening Complications of Influenza vs Coronavirus Disease 2019 (COVID-19) in US Children |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.02.2023 | ||
| 500 | |a Date Revised 29.09.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com. | ||
| 520 | |a BACKGROUND: Clinical differences between critical illness from influenza infection vs coronavirus disease 2019 (COVID-19) have not been well characterized in pediatric patients | ||
| 520 | |a METHODS: We compared demographics, clinical characteristics, and outcomes of US children (aged 8 months to 17 years) admitted to the intensive care or high-acuity unit with influenza or COVID-19. Using mixed-effects models, we assessed the odds of death or requiring life support for influenza vs COVID-19 after adjustment for age, sex, race and Hispanic origin, and underlying conditions including obesity | ||
| 520 | |a RESULTS: Children with influenza (n = 179) were younger than those with COVID-19 (n = 381; median, 5.2 years vs 13.8 years), less likely to be non-Hispanic Black (14.5% vs 27.6%) or Hispanic (24.0% vs 36.2%), and less likely to have ≥1 underlying condition (66.4% vs 78.5%) or be obese (21.4% vs 42.2%), and a shorter hospital stay (median, 5 days vs 7 days). They were similarly likely to require invasive mechanical ventilation (both 30.2%), vasopressor support (19.6% and 19.9%), or extracorporeal membrane oxygenation (2.2% and 2.9%). Four children with influenza (2.2%) and 11 children with COVID-19 (2.9%) died. The odds of death or requiring life support in children with influenza vs COVID-19 were similar (adjusted odds ratio, 1.30; 95% confidence interval, .78-2.15; P = .32) | ||
| 520 | |a CONCLUSIONS: Despite differences in demographics and clinical characteristics of children with influenza or COVID-19, the frequency of life-threatening complications was similar. Our findings highlight the importance of implementing prevention measures to reduce transmission and disease severity of influenza and COVID-19 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, U.S. Gov't, P.H.S. | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a children | |
| 650 | 4 | |a influenza | |
| 650 | 4 | |a intensive care units | |
| 700 | 1 | |a Spieker, Andrew J |e verfasserin |4 aut | |
| 700 | 1 | |a Young, Cameron C |e verfasserin |4 aut | |
| 700 | 1 | |a Olson, Samantha M |e verfasserin |4 aut | |
| 700 | 1 | |a Newhams, Margaret M |e verfasserin |4 aut | |
| 700 | 1 | |a Amarin, Justin Z |e verfasserin |4 aut | |
| 700 | 1 | |a Moffitt, Kristin L |e verfasserin |4 aut | |
| 700 | 1 | |a Nakamura, Mari M |e verfasserin |4 aut | |
| 700 | 1 | |a Levy, Emily R |e verfasserin |4 aut | |
| 700 | 1 | |a Soma, Vijaya L |e verfasserin |4 aut | |
| 700 | 1 | |a Talj, Rana |e verfasserin |4 aut | |
| 700 | 1 | |a Weiss, Scott L |e verfasserin |4 aut | |
| 700 | 1 | |a Fitzgerald, Julie C |e verfasserin |4 aut | |
| 700 | 1 | |a Mack, Elizabeth H |e verfasserin |4 aut | |
| 700 | 1 | |a Maddux, Aline B |e verfasserin |4 aut | |
| 700 | 1 | |a Schuster, Jennifer E |e verfasserin |4 aut | |
| 700 | 1 | |a Coates, Bria M |e verfasserin |4 aut | |
| 700 | 1 | |a Hall, Mark W |e verfasserin |4 aut | |
| 700 | 1 | |a Schwartz, Stephanie P |e verfasserin |4 aut | |
| 700 | 1 | |a Schwarz, Adam J |e verfasserin |4 aut | |
| 700 | 1 | |a Kong, Michele |e verfasserin |4 aut | |
| 700 | 1 | |a Spinella, Philip C |e verfasserin |4 aut | |
| 700 | 1 | |a Loftis, Laura L |e verfasserin |4 aut | |
| 700 | 1 | |a McLaughlin, Gwenn E |e verfasserin |4 aut | |
| 700 | 1 | |a Hobbs, Charlotte V |e verfasserin |4 aut | |
| 700 | 1 | |a Rowan, Courtney M |e verfasserin |4 aut | |
| 700 | 1 | |a Bembea, Melania M |e verfasserin |4 aut | |
| 700 | 1 | |a Nofziger, Ryan A |e verfasserin |4 aut | |
| 700 | 1 | |a Babbitt, Christopher J |e verfasserin |4 aut | |
| 700 | 1 | |a Bowens, Cindy |e verfasserin |4 aut | |
| 700 | 1 | |a Flori, Heidi R |e verfasserin |4 aut | |
| 700 | 1 | |a Gertz, Shira J |e verfasserin |4 aut | |
| 700 | 1 | |a Zinter, Matt S |e verfasserin |4 aut | |
| 700 | 1 | |a Giuliano, John S |e verfasserin |4 aut | |
| 700 | 1 | |a Hume, Janet R |e verfasserin |4 aut | |
| 700 | 1 | |a Cvijanovich, Natalie Z |e verfasserin |4 aut | |
| 700 | 1 | |a Singh, Aalok R |e verfasserin |4 aut | |
| 700 | 1 | |a Crandall, Hillary A |e verfasserin |4 aut | |
| 700 | 1 | |a Thomas, Neal J |e verfasserin |4 aut | |
| 700 | 1 | |a Cullimore, Melissa L |e verfasserin |4 aut | |
| 700 | 1 | |a Patel, Manish M |e verfasserin |4 aut | |
| 700 | 1 | |a Randolph, Adrienne G |e verfasserin |4 aut | |
| 700 | 0 | |a Pediatric Intensive Care Influenza |e verfasserin |4 aut | |
| 700 | 0 | |a Overcoming COVID-19 Investigators |e verfasserin |4 aut | |
| 700 | 1 | |a Kong, Michele |e investigator |4 oth | |
| 700 | 1 | |a Gaspers, Mary Glas |e investigator |4 oth | |
| 700 | 1 | |a Typpo, Katri V |e investigator |4 oth | |
| 700 | 1 | |a Sanders, Ronald C |e investigator |4 oth | |
| 700 | 1 | |a Katherine, Irby |e investigator |4 oth | |
| 700 | 1 | |a Peter, Mourani |e investigator |4 oth | |
| 700 | 1 | |a Schwarz, Adam J |e investigator |4 oth | |
| 700 | 1 | |a Babbitt, Christopher J |e investigator |4 oth | |
| 700 | 1 | |a Helen, Harvey |e investigator |4 oth | |
| 700 | 1 | |a Cvijanovich, Natalie Z |e investigator |4 oth | |
| 700 | 1 | |a Zinter, Matt S |e investigator |4 oth | |
| 700 | 1 | |a Maddux, Aline B |e investigator |4 oth | |
| 700 | 1 | |a Osborne, Christina M |e investigator |4 oth | |
| 700 | 1 | |a Sara, Shankman |e investigator |4 oth | |
| 700 | 1 | |a Mourani, Peter M |e investigator |4 oth | |
| 700 | 1 | |a Emily, Port |e investigator |4 oth | |
| 700 | 1 | |a Van, Kevin A |e investigator |4 oth | |
| 700 | 1 | |a Carroll, Christopher L |e investigator |4 oth | |
| 700 | 1 | |a Giuliano, John S |e investigator |4 oth | |
| 700 | 1 | |a McLaughlin, Gwenn E |e investigator |4 oth | |
| 700 | 1 | |a Tarquinio, Keiko M |e investigator |4 oth | |
| 700 | 1 | |a Michelson, Kelly N |e investigator |4 oth | |
| 700 | 1 | |a Coates, Bria M |e investigator |4 oth | |
| 700 | 1 | |a Rowan, Courtney M |e investigator |4 oth | |
| 700 | 1 | |a Wellnitz, Kari |e investigator |4 oth | |
| 700 | 1 | |a Bhoojhawon, Guru |e investigator |4 oth | |
| 700 | 1 | |a Sullivan, Janice E |e investigator |4 oth | |
| 700 | 1 | |a Montgomery, Vicki L |e investigator |4 oth | |
| 700 | 1 | |a Havlin, Kevin M |e investigator |4 oth | |
| 700 | 1 | |a Bradford, Tamara T |e investigator |4 oth | |
| 700 | 1 | |a Riggs, Becky J |e investigator |4 oth | |
| 700 | 1 | |a Bembea, Melania M |e investigator |4 oth | |
| 700 | 1 | |a Randolph, Adrienne G |e investigator |4 oth | |
| 700 | 1 | |a Newhams, Margaret M |e investigator |4 oth | |
| 700 | 1 | |a Chen, Sabrina R |e investigator |4 oth | |
| 700 | 1 | |a Young, Cameron C |e investigator |4 oth | |
| 700 | 1 | |a Moffitt, Kristin L |e investigator |4 oth | |
| 700 | 1 | |a Nakamura, Mari M |e investigator |4 oth | |
| 700 | 1 | |a Carroll, Ryan W |e investigator |4 oth | |
| 700 | 1 | |a Yager, Phoebe H |e investigator |4 oth | |
| 700 | 1 | |a Fernandes, Neil D |e investigator |4 oth | |
| 700 | 1 | |a Flori, Heidi R |e investigator |4 oth | |
| 700 | 1 | |a Heidemann, Sabrina M |e investigator |4 oth | |
| 700 | 1 | |a Hume, Janet R |e investigator |4 oth | |
| 700 | 1 | |a Levy, Emily R |e investigator |4 oth | |
| 700 | 1 | |a Hobbs, Charlotte V |e investigator |4 oth | |
| 700 | 1 | |a Martin, Lora |e investigator |4 oth | |
| 700 | 1 | |a Malloch, Lacy |e investigator |4 oth | |
| 700 | 1 | |a Inagaki, Kengo |e investigator |4 oth | |
| 700 | 1 | |a Dhanrajani, Anita |e investigator |4 oth | |
| 700 | 1 | |a Schuster, Jennifer E |e investigator |4 oth | |
| 700 | 1 | |a Kietzman, Abigail |e investigator |4 oth | |
| 700 | 1 | |a Hill, Shannon |e investigator |4 oth | |
| 700 | 1 | |a Spinella, Philip C |e investigator |4 oth | |
| 700 | 1 | |a Cullimore, Melissa L |e investigator |4 oth | |
| 700 | 1 | |a McCulloh, Russell J |e investigator |4 oth | |
| 700 | 1 | |a Clouser, Katharine N |e investigator |4 oth | |
| 700 | 1 | |a Gertz, Shira J |e investigator |4 oth | |
| 700 | 1 | |a Kleinman, Lawrence C |e investigator |4 oth | |
| 700 | 1 | |a Li, Simon |e investigator |4 oth | |
| 700 | 1 | |a Horwitz, Steven M |e investigator |4 oth | |
| 700 | 1 | |a Ratner, Adam J |e investigator |4 oth | |
| 700 | 1 | |a Dapul, Heda |e investigator |4 oth | |
| 700 | 1 | |a Soma, Vijaya L |e investigator |4 oth | |
| 700 | 1 | |a Keenaghan, Michael A |e investigator |4 oth | |
| 700 | 1 | |a Singh, Aalok R |e investigator |4 oth | |
| 700 | 1 | |a Harwayne-Gidansky, Ilana |e investigator |4 oth | |
| 700 | 1 | |a Hymes, Saul R |e investigator |4 oth | |
| 700 | 1 | |a Doymaz, Sule |e investigator |4 oth | |
| 700 | 1 | |a Schwartz, Stephanie P |e investigator |4 oth | |
| 700 | 1 | |a Walker, Tracie C |e investigator |4 oth | |
| 700 | 1 | |a Hall, Mark W |e investigator |4 oth | |
| 700 | 1 | |a Shein, Steven L |e investigator |4 oth | |
| 700 | 1 | |a Lansell, Amanda N |e investigator |4 oth | |
| 700 | 1 | |a Nofziger, Ryan A |e investigator |4 oth | |
| 700 | 1 | |a Staat, Mary A |e investigator |4 oth | |
| 700 | 1 | |a Fitzgerald, Julie C |e investigator |4 oth | |
| 700 | 1 | |a Weiss, Scott |e investigator |4 oth | |
| 700 | 1 | |a Thomas, Neal J |e investigator |4 oth | |
| 700 | 1 | |a Fink, Ericka L |e investigator |4 oth | |
| 700 | 1 | |a Carcillo, Joseph A |e investigator |4 oth | |
| 700 | 1 | |a Mack, Elizabeth H |e investigator |4 oth | |
| 700 | 1 | |a Smallcomb, Laura S |e investigator |4 oth | |
| 700 | 1 | |a Halasa, Natasha B |e investigator |4 oth | |
| 700 | 1 | |a Stewart, Laura |e investigator |4 oth | |
| 700 | 1 | |a Romero, Yesenia |e investigator |4 oth | |
| 700 | 1 | |a Hayek, Haya |e investigator |4 oth | |
| 700 | 1 | |a Loftis, Laura L |e investigator |4 oth | |
| 700 | 1 | |a Munoz, Alvaro Coronado |e investigator |4 oth | |
| 700 | 1 | |a Bowens, Cindy |e investigator |4 oth | |
| 700 | 1 | |a Maamari, Mia |e investigator |4 oth | |
| 700 | 1 | |a Crandall, Hillary |e investigator |4 oth | |
| 700 | 1 | |a Smith, Lincoln S |e investigator |4 oth | |
| 700 | 1 | |a McGuire, John K |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |d 1992 |g 76(2023), 3 vom: 08. Feb., Seite e280-e290 |w (DE-627)NLM012603007 |x 1537-6591 |7 nnns |
| 773 | 1 | 8 | |g volume:76 |g year:2023 |g number:3 |g day:08 |g month:02 |g pages:e280-e290 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/cid/ciac477 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 76 |j 2023 |e 3 |b 08 |c 02 |h e280-e290 | ||